-+ 0.00%
-+ 0.00%
-+ 0.00%

Picard Medical Completes First In Vivo Implantations Of Fully Implantable Emperor Total Artificial Heart

Benzinga·11/19/2025 21:07:53
Listen to the news

Picard Medical, Inc. (NYSE American: PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it has successfully completed the first in vivo implantations of the fully implantable Emperor Total Artificial Heart (TAH). The positive outcomes observed following the implantations mark a major milestone in the development of the Emperor platform as the next-generation successor to the clinically proven, FDA-approved SynCardia Total Artificial Heart ("STAH").